TCF/LEF transcription factors emerge as druggable targets in Wnt signaling, offering new hope for fibrosis and cancer therapies
Researchers have unveiled the intricate molecular mechanisms governing TCF/LEF-mediated transcription in the canonical Wnt pathway, identifying these proteins as promising therapeutic targets for cancer and fibrotic diseases. The review, published in Current Molecular Pharmacology, systematically dissects how four mammalian TCF/LEF paralogs—TCF7, LEF1, TCF7L1, and TCF7L2—achieve functional specificity through modular domain architecture and extensive alternative splicing.
"TCF/LEF proteins function as the final integrators of Wnt signals, converting β-catenin ...